enGene Holdings Inc. (NASDAQ: ENGN)
$6.2400
-0.0800 ( +2.30% ) 30.0K
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.
Market Data
Open
$6.2400
Previous close
$6.3200
Volume
30.0K
Market cap
$322.17M
Day range
$6.0550 - $6.8490
52 week range
$4.4200 - $18.4000
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
3 | Insider transactions | 2 | May 17, 2024 |
8-k | 8K-related | 12 | May 15, 2024 |
4 | Insider transactions | 1 | Apr 22, 2024 |
def | Proxies and info statements | 4 | Apr 18, 2024 |
ars | Annual reports | 1 | Apr 18, 2024 |
4 | Insider transactions | 1 | Mar 25, 2024 |
4 | Insider transactions | 1 | Mar 20, 2024 |
4 | Insider transactions | 1 | Mar 19, 2024 |
10-q | Quarterly Reports | 83 | Mar 11, 2024 |
8-k | 8K-related | 14 | Mar 11, 2024 |